Olivier Bouché

23PUBLICATIONS
182CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsPeripheral nervous systemCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jun 08, 2026
Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors.

|Feb 11, 2026
Circulating Tumor DNA Dynamics and Clinical Outcomes in Patients with Advanced Colorectal Cancer Treated with Cetuximab-Based Induction and Maintenance Treatment.

Valérie Boige, Olivier Bouché, Claire Mulot

|Nov 07, 2025
Methodological approach to optimize a step-by-step deterministic linkage of SNDS data with a clinical database (FREGAT) of gastric/gastroesophageal junction adenocarcinoma in France: Pitfalls and learnings.

Magali Laborey, Audrey Lajoinie, Jonatan Freilich

|Nov 04, 2025
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.

Pascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade

|May 16, 2025
PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma.

Michel Ducreux, Romain Desgrippes, Yves Rinaldi

|Apr 04, 2025
Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study).

Lilian Schwarz, Jean-Baptiste Bachet, Aurelia Meurisse

Pageof 4

Frequent Collaborators

4 joint publications

Marine Perrier

3 joint publications

Jean-Baptiste Bachet

3 joint publications

Thierry Lecomte

3 joint publications

Christelle de la Fouchardiere